The Effect of N115 on Coughing in IPF Patients

NCT06037408 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: 20mM sodium pyruvate nasal spray
OTHER: Saline Placebo control nasal spray

Sponsor

Cellular Sciences, inc.

Collaborators

[object Object]